Mirum Pharmaceuticals, Inc.(MIRM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MIRM Mirum Pharmaceuticals, Inc.

交易中 12-20 15:27:34 EST

41.74

+0.61

+1.49%

最高42.85	最低40.58	成交量21.70万
今开40.58	昨收41.13	日振幅5.52%
总市值20.04亿	流通市值15.66亿	总股本4,800万
成交额900.97万	换手率0.58%	流通股本3,753万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MIRM","market":"US","secType":"STK","nameCN":"Mirum Pharmaceuticals, Inc.","latestPrice":41.7425,"timestamp":1734726450199,"preClose":41.13,"halted":0,"volume":216958,"delay":0,"floatShares":37525378,"shares":48004582,"eps":-2.119862,"marketStatus":"交易中","marketStatusCode":2,"change":0.6125,"latestTime":"12-20 15:27:34 EST","open":40.58,"high":42.85,"low":40.58,"amount":9009749.813876,"amplitude":0.055191,"askPrice":41.76,"askSize":68,"bidPrice":41.65,"bidSize":429,"shortable":3,"etf":0,"ttmEps":-2.119862,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734728400000},"adr":0,"listingDate":1563422400000,"adjPreClose":41.13,"preHourTrading":{"tag":"盘前","latestPrice":40.55,"preClose":41.13,"latestTime":"09:29 EST","volume":940,"amount":38543.995,"timestamp":1734704999060},"postHourTrading":{"tag":"盘后","latestPrice":41.13,"preClose":41.13,"latestTime":"19:11 EST","volume":24734,"amount":1017288.18,"timestamp":1734653517921},"volumeRatio":0.545982,"impliedVol":0.758,"impliedVolPercentile":0.7738},"requestUrl":"/m/hq/s/MIRM","defaultTab":"news","newsList":[{"id":"2492515633","title":"Mirum Pharmaceuticals, Inc.盘中异动 下午盘急速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492515633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492515633?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:28","pubTimestamp":1734553739,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时28分，Mirum Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.03%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.38%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。它参与了 Maralixibat 的开发，用于治疗患有进行性家族性肝内胆汁淤积症或 PFIC 和 Alagille 综合征或 ALGS 的儿科患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219042859a1f954ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219042859a1f954ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MIRM"],"gpt_icon":0},{"id":"2490776405","title":"Mirum Pharmaceuticals, Inc.盘中异动 快速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490776405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490776405?lang=zh_cn&edition=full","pubTime":"2024-12-09 23:04","pubTimestamp":1733756678,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日23时04分，Mirum Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.06%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。它参与了 Maralixibat 的开发，用于治疗患有进行性家族性肝内胆汁淤积症或 PFIC 和 Alagille 综合征或 ALGS 的儿科患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120923043895e869f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120923043895e869f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MIRM"],"gpt_icon":0},{"id":"2484677712","title":"Mirum Pharmaceuticals, Inc.2024财年第三财季实现净利润-14.24百万美元，同比增加39.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484677712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484677712?lang=zh_cn&edition=full","pubTime":"2024-11-19 00:00","pubTimestamp":1731945623,"startTime":"0","endTime":"0","summary":"11月19日，Mirum Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为-14.24百万美元，同比增加39.64%；其中营业收入为90.38百万美元，同比增加89.36%，每股基本收益为-0.30美元。从资产负债表来看，Mirum Pharmaceuticals, Inc.总负债4.36亿美元，其中短期债务1.51百万美元，资产负债比为1.54，流动比率为3.34。机构评级：截至2024年11月19日，当前有10家机构对Mirum Pharmaceuticals, Inc.目标价做出预测，其中目标均价为63.40美元，其中最低目标价为50.00美元，最高目标价为73.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000033a243525b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000033a243525b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIRM"],"gpt_icon":0},{"id":"2484867157","title":"Mirum Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484867157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484867157?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:48","pubTimestamp":1731941293,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时48分，Mirum Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.21%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为546.09%、372.67%、280.16%，振幅较大的相关个股有Hcw Biologics Inc.、Fate Therapeutics, Inc.、冠科美博，振幅分别为118.81%、62.38%、54.54%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822481398e4344a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822481398e4344a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MIRM"],"gpt_icon":0},{"id":"2483584877","title":"Mirum Pharmaceuticals, Inc.盘中异动 股价大跌5.04%报43.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483584877","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483584877?lang=zh_cn&edition=full","pubTime":"2024-11-16 03:28","pubTimestamp":1731698936,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日03时28分，Mirum Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.04%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为3.82%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111603285698e43050&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111603285698e43050&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIRM","BK4139"],"gpt_icon":0},{"id":"2483785150","title":"Mirum Pharmaceuticals, Inc.盘中异动 下午盘急速拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483785150","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483785150?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:38","pubTimestamp":1731526697,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日03时38分，Mirum Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.09%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为616.91%、553.14%、161.93%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为139.00%、86.83%、73.71%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114033817971a65d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114033817971a65d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MIRM"],"gpt_icon":0},{"id":"2482082389","title":"Mirum Pharmaceuticals Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482082389","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482082389?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:30","pubTimestamp":1731425405,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要Mirum Pharmaceuticals Inc MIRM.OQ报告，截至9月30日的季度调整后每股亏损30美分，高于去年同期的每股-57美分。十位分析师对该季度的平均预期是每股亏损 45 美分。Mirum Pharmaceuticals Inc 公布的本季度每股收益为亏损 30 美分。Mirum Pharmaceuticals Inc 的股价本季度上涨了 6.7%，今年迄今为止上涨了 41.0%。华尔街对 Mirum Pharmaceuticals Inc 的 12 个月目标价中位数为 65.50 本摘要由 LSEG 11 月 12 日 03:29 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL4S3MJ1Q4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MIRM"],"gpt_icon":0},{"id":"2482008137","title":"BUZZ-Mirum 因 2024 年收入预期上调而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2482008137","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482008137?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:13","pubTimestamp":1731424409,"startTime":"0","endTime":"0","summary":"    11月12日 - ** Mirum Pharmaceuticals   股价上涨5.7%至43.97美元** 公司将 2024 年的营业额预期从之前的 3.1 亿至 3.2 亿美元上调至 3.3 亿至 3.35 亿美元。**  公布第三季度营业收入为 9,030 万美元，高于分析师预计的 8,200 万美元 - LSEG** 公布第三季度每股亏损 30 美分，低于分析师预计的 45 美分 - LSEG** 公司的肝病药物 Livmarli 第三季度实现营业收入 5910 万美元，高于分析师预计的 5000 万美元 - LSEG** 覆盖 MIRM 的所有 11 家券商均将该股评为 \"买入 \"或更高；中位数 PT 为 65.50 美元 - LSEG** 该股今年累计上涨约49%，包括盘中涨幅","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIRM","BK4139"],"gpt_icon":0},{"id":"2482708509","title":"Mirum Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.59%报44.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482708509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482708509?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:32","pubTimestamp":1731421937,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时32分，Mirum Pharmaceuticals, Inc.股票出现波动，股价快速拉升6.59%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。它参与了 Maralixibat 的开发，用于治疗患有进行性家族性肝内胆汁淤积症或 PFIC 和 Alagille 综合征或 ALGS 的儿科患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222321795be1973&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222321795be1973&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIRM","BK4139"],"gpt_icon":0},{"id":"2482148596","title":"Mirum Pharmaceuticals Inc    预计每股亏损 45 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482148596","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482148596?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:59","pubTimestamp":1731081550,"startTime":"0","endTime":"0","summary":"   * Mirum Pharmaceuticals Inc    将于11月12日公布截至2024年9月30日的季度财报，预计该公司的季度收入将有所增长。* LSEG 分析师对 Mirum Pharmaceuticals Inc 的平均预期是每股亏损 45 美分。* 华尔街对 Mirum Pharmaceuticals Inc 的 12 个月目标价中位数为 65.50 美元，高于其最新收盘价 41.08 美元。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Mirum Pharmaceuticals Inc    预计每股亏损 45 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIRM"],"gpt_icon":0},{"id":"2481688239","title":"Mirum Pharmaceuticals, Inc.盘中异动 快速下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481688239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481688239?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:31","pubTimestamp":1730817070,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时31分，Mirum Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.12%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110522311098e408bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110522311098e408bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MIRM"],"gpt_icon":0},{"id":"2480853073","title":"Mirum Pharmaceuticals, Inc.盘中异动 快速拉升5.36%报40.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480853073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480853073?lang=zh_cn&edition=full","pubTime":"2024-11-02 02:25","pubTimestamp":1730485508,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日02时25分，Mirum Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.36%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102022508a20aa9ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102022508a20aa9ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIRM","BK4139"],"gpt_icon":0},{"id":"2468501797","title":"Mirum Pharmaceuticals, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468501797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468501797?lang=zh_cn&edition=full","pubTime":"2024-09-19 23:32","pubTimestamp":1726759973,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日23时32分，Mirum Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.05%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.68%。其相关个股中，Exicure, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Edgewise Therapeutics, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃，换手率分别为4241.49%、802.12%、183.80%，振幅较大的相关个股有Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为101.31%、78.69%、52.97%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919233253a1db365a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919233253a1db365a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MIRM"],"gpt_icon":0},{"id":"2460924136","title":"Mirum Pharmaceuticals, Inc.2024财年第二财季实现净利润-24.64百万美元，同比增加66.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460924136","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460924136?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824029,"startTime":"0","endTime":"0","summary":"8月17日，Mirum Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为-24.64百万美元，同比增加66.72%；其中营业收入为77.88百万美元，同比增加107.68%，每股基本收益为-0.52美元。从资产负债表来看，Mirum Pharmaceuticals, Inc.总负债4.32亿美元，其中短期债务1.07百万美元，资产负债比为1.54，流动比率为3.29。机构评级：截至2024年8月17日，当前有11家机构对Mirum Pharmaceuticals, Inc.目标价做出预测，其中目标均价为59.27美元，其中最低目标价为39.00美元，最高目标价为71.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170004269f31af5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170004269f31af5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIRM"],"gpt_icon":0},{"id":"2459188455","title":"Mirum Pharmaceuticals, Inc.盘中异动 股价大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459188455","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459188455?lang=zh_cn&edition=full","pubTime":"2024-08-13 22:45","pubTimestamp":1723560308,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日22时45分，Mirum Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.32%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.68%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。它参与了 Maralixibat 的开发，用于治疗患有进行性家族性肝内胆汁淤积症或 PFIC 和 Alagille 综合征或 ALGS 的儿科患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813224509ab5d9c34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813224509ab5d9c34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MIRM"],"gpt_icon":0},{"id":"2458984844","title":"Mirum Pharmaceuticals, Inc.盘中异动 大幅拉升5.09%报42.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458984844","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458984844?lang=zh_cn&edition=full","pubTime":"2024-08-12 22:35","pubTimestamp":1723473336,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日22时35分，Mirum Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.09%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812223536aefe6d34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812223536aefe6d34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MIRM"],"gpt_icon":0},{"id":"2457605341","title":"Mirum Pharmaceuticals Inc    预计每股亏损 47 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457605341","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457605341?lang=zh_cn&edition=full","pubTime":"2024-08-06 10:24","pubTimestamp":1722911054,"startTime":"0","endTime":"0","summary":"   * Mirum Pharmaceuticals Inc    将于8月7日公布截至2024年6月30日的季度财报，预计该公司的季度收入将有所增长。* LSEG 分析师对 Mirum Pharmaceuticals Inc 的平均预期是每股亏损 47 美分。* 华尔街对 Mirum Pharmaceuticals Inc 的 12 个月目标价中位数为 63.00 美元，高于其上一次收盘价 38.50 美元。8月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Mirum Pharmaceuticals Inc    预计每股亏损 47 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIRM"],"gpt_icon":0},{"id":"2455953233","title":"Mirum Pharmaceuticals Inc    预计每股亏损 47 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2455953233","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455953233?lang=zh_cn&edition=full","pubTime":"2024-07-30 22:18","pubTimestamp":1722349102,"startTime":"0","endTime":"0","summary":"   * Mirum Pharmaceuticals Inc    预计将在8月1日公布截至2024年6月30日的季度业绩(估计)，季度收入将有所增长。* LSEG 分析师对 Mirum Pharmaceuticals Inc 的平均预期是每股亏损 47 美分。* 华尔街对 Mirum Pharmaceuticals Inc 的 12 个月目标价中位数为 63.00 美元，高于其上次收盘价 42.05 美元。7月30日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIRM"],"gpt_icon":0},{"id":"2454371029","title":"Mirum Pharmaceuticals, Inc.盘中异动 下午盘急速拉升5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454371029","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454371029?lang=zh_cn&edition=full","pubTime":"2024-07-27 02:51","pubTimestamp":1722019903,"startTime":"0","endTime":"0","summary":"北京时间2024年07月27日02时51分，Mirum Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.18%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240727025144941fb2af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240727025144941fb2af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MIRM"],"gpt_icon":0},{"id":"2454977870","title":"Mirum Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.04%报41.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454977870","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454977870?lang=zh_cn&edition=full","pubTime":"2024-07-25 22:27","pubTimestamp":1721917676,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日22时27分，Mirum Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.04%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。其相关个股中，Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.、Viking Therapeutics, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Azitra Inc较为活跃，换手率分别为2223.19%、432.32%、174.44%，振幅较大的相关个股有Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为117.35%、98.60%、82.05%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725222756aefb7846&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725222756aefb7846&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MIRM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mirumpharma.com","stockEarnings":[{"period":"1week","weight":-0.0272},{"period":"1month","weight":-0.0228},{"period":"3month","weight":0.0557},{"period":"6month","weight":0.2833},{"period":"1year","weight":0.3358},{"period":"ytd","weight":0.3933}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.0071},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.0764},{"period":"1year","weight":0.2517},{"period":"ytd","weight":0.2331}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mirum Pharmaceuticals, Inc.于2018年5月2日在特拉华州注册成立。该公司是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见和孤儿疾病的新疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.005217},{"month":2,"riseRate":1,"avgChangeRate":0.07935},{"month":3,"riseRate":0.4,"avgChangeRate":-0.049861},{"month":4,"riseRate":0.6,"avgChangeRate":0.078073},{"month":5,"riseRate":0,"avgChangeRate":-0.047798},{"month":6,"riseRate":0.6,"avgChangeRate":0.08826},{"month":7,"riseRate":0.6,"avgChangeRate":0.088394},{"month":8,"riseRate":0.666667,"avgChangeRate":0.053993},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.049627},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.124045},{"month":11,"riseRate":0.666667,"avgChangeRate":0.097857},{"month":12,"riseRate":0.5,"avgChangeRate":0.3537}],"exchange":"NASDAQ","name":"Mirum Pharmaceuticals, Inc.","nameEN":"Mirum Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mirum Pharmaceuticals, Inc.(MIRM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mirum Pharmaceuticals, Inc.(MIRM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mirum Pharmaceuticals, Inc.,MIRM,Mirum Pharmaceuticals, Inc.股票,Mirum Pharmaceuticals, Inc.股票老虎,Mirum Pharmaceuticals, Inc.股票老虎国际,Mirum Pharmaceuticals, Inc.行情,Mirum Pharmaceuticals, Inc.股票行情,Mirum Pharmaceuticals, Inc.股价,Mirum Pharmaceuticals, Inc.股市,Mirum Pharmaceuticals, Inc.股票价格,Mirum Pharmaceuticals, Inc.股票交易,Mirum Pharmaceuticals, Inc.股票购买,Mirum Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mirum Pharmaceuticals, Inc.(MIRM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mirum Pharmaceuticals, Inc.(MIRM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}